Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023
Rhea-AI Summary
Mesa Laboratories, Inc. (NASDAQ:MLAB) plans to release its financial results for the fourth quarter and fiscal year ending March 31, 2023, on May 25, 2023, at 8:00 A.M. Eastern time. The company is recognized as a global leader in designing and manufacturing life science tools and critical quality control solutions, targeting regulated applications in sectors like pharmaceuticals, healthcare, and medical devices.
Mesa operates through four divisions: Sterilization and Disinfection Control, Biopharmaceutical Development, Clinical Genomics, and Calibration Solutions, focusing on product integrity and patient safety.
Positive
- None.
Negative
- None.
News Market Reaction – MLAB
In the trading session that priced this news, MLAB gained 0.60%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKEWOOD, Colo., March 09, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2023 at approximately 8:00 A.M. Eastern time on Thursday, May 25, 2023.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Clinical Genomics, and Calibration Solutions) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
For more information about the Company, please visit its website at www.mesalabs.com
